Equities

Zynex Inc

ZYXI:NSQ

Zynex Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)8.26
  • Today's Change0.150 / 1.85%
  • Shares traded63.59k
  • 1 Year change-9.03%
  • Beta0.5026
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments452043
Total Receivables, Net273529
Total Inventory131311
Prepaid expenses3.330.870.69
Other current assets, total------
Total current assets887083
Property, plant & equipment, net161519
Goodwill, net202020
Intangibles, net8.169.079.98
Long term investments------
Note receivable - long term------
Other long term assets0.410.590.59
Total assets137116133
LIABILITIES
Accounts payable------
Accrued expenses9.278.016.76
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.205.465.45
Other current liabilities, total0.632.015.93
Total current liabilities192123
Total long term debt585.4811
Total debt581116
Deferred income tax------
Minority interest------
Other liabilities, total142426
Total liabilities915059
SHAREHOLDERS EQUITY
Common stock0.030.040.04
Additional paid-in capital918280
Retained earnings (accumulated deficit)27170
Treasury stock - common(72)(33)(6.51)
Unrealized gain (loss)------
Other equity, total------
Total equity466674
Total liabilities & shareholders' equity137116133
Total common shares outstanding333740
Treasury shares - common primary issue8.554.251.25
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.